The transcription factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells

Cell Reports

Volumn 8, Issue 1, 2014, Pages 150-162

  Hughes, Tiffany ^a   Briercheck, Edward L ^b   Freud, Aharon G ^b,c   Trotta, Rossana ^a   McClory, Susan ^b   Scoville, Steven D ^b   Keller, Karen ^a   Deng, Youcai ^a   Cole, Jordan ^a   Harrison, Nicholas ^a   Mao, Charlene ^a   Zhang, Jianying ^b   Benson, Don M ^a,c   Yu, Jianhua ^a,c   Caligiuri, Michael A ^a,b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; EOMESODERMIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 22; MESSENGER RNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR T BET; INTERLEUKIN 1 RECEPTOR; AHR PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD56 ANTIGEN; IL1R1 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ARTICLE; CELL MATURATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DRUG ANTAGONISM; EX VIVO STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE LYMPHOID CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOID CELL; NATURAL KILLER CELL; PLASTICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL DIFFERENTIATION; CELL ISOLATION; FLOW CYTOMETRY; HUMAN CELL CULTURE; HUMAN TISSUE; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONSIL; CELL CULTURE; CELL LINEAGE; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PALATINE TONSIL;

ANTIGENS, CD56; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; HUMANS; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOCYTES; PALATINE TONSIL; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, INTERLEUKIN-1 TYPE I;

EID: 84904045048     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.042     Document Type: Article

References (63)

1. Ahn Y.O., Blazar B.R., Miller J.S., Verneris M.R. Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells. Blood 2013, 121:2234-2243.
2. Bernink J.H., Peters C.P., Munneke M., te Velde A.A., Meijer S.L., Weijer K., Hreggvidsdottir H.S., Heinsbroek S.E., Legrand N., Buskens C.J., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 2013, 14:221-229.
3. Boitano A.E., Wang J., Romeo R., Bouchez L.C., Parker A.E., Sutton S.E., Walker J.R., Flaveny C.A., Perdew G.H., Denison M.S., et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010, 329:1345-1348.
4. Burbach K.M., Poland A., Bradfield C.A. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA 1992, 89:8185-8189.
5. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., Caligiuri M.A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J.Exp. Med. 1994, 180:1395-1403.
6. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., Doherty J.M., Mills J.C., Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
7. Cella M., Otero K., Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc. Natl. Acad. Sci. USA 2010, 107:10961-10966.
8. Colucci F., Di Santo J.P. The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells. Blood 2000, 95:984-991.
9. Cooper M.A., Fehniger T.A., Ponnappan A., Mehta V., Wewers M.D., Caligiuri M.A. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells. Eur. J. Immunol. 2001, 31:792-801.
10. Cooper M.A., Bush J.E., Fehniger T.A., VanDeusen J.B., Waite R.E., Liu Y., Aguila H.L., Caligiuri M.A. Invivo evidence for a dependence oninterleukin 15 for survival of natural killer cells. Blood 2002, 100:3633-3638.
11. Crellin N.K., Trifari S., Kaplan C.D., Cupedo T., Spits H. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J.Exp. Med. 2010, 207:281-290.
12. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., Fibbe W.E., Cornelissen J.J., Spits H. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 2009, 10:66-74.
13. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003, 43:309-334.
14. DiNatale B.C., Schroeder J.C., Perdew G.H. Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines. Mol. Carcinog. 2011, 50:173-183.
15. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J.Immunol. 1999, 162:4511-4520.
16. Frericks M., Meissner M., Esser C. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol. Appl. Pharmacol. 2007, 220:320-332.
17. Freud A.G., Caligiuri M.A. Human natural killer cell development. Immunol. Rev. 2006, 214:56-72.
18. Freud A.G., Becknell B., Roychowdhury S., Mao H.C., Ferketich A.K., Nuovo G.J., Hughes T.L., Marburger T.B., Sung J., Baiocchi R.A., et al. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 2005, 22:295-304.
19. Freud A.G., Yokohama A., Becknell B., Lee M.T., Mao H.C., Ferketich A.K., Caligiuri M.A. Evidence for discrete stages of human natural killer cell differentiation invivo. J.Exp. Med. 2006, 203:1033-1043.
20. Gill S., Vasey A.E., De Souza A., Baker J., Smith A.T., Kohrt H.E., Florek M., Gibbs K.D., Tate K., Ritchie D.S., Negrin R.S. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. Blood 2012, 119:5758-5768.
21. Gordon S.M., Chaix J., Rupp L.J., Wu J., Madera S., Sun J.C., Lindsten T., Reiner S.L. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012, 36:55-67.
22. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 1995, 35:307-340.
23. Hughes T., Becknell B., McClory S., Briercheck E., Freud A.G., Zhang X., Mao H., Nuovo G., Yu J., Caligiuri M.A. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 2009, 113:4008-4010.
24. Hughes T., Becknell B., Freud A.G., McClory S., Briercheck E., Yu J., Mao C., Giovenzana C., Nuovo G., Wei L., et al. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010, 32:803-814.
25. Intlekofer A.M., Takemoto N., Wherry E.J., Longworth S.A., Northrup J.T., Palanivel V.R., Mullen A.C., Gasink C.R., Kaech S.M., Miller J.D., et al. Effector and memory CD8+ Tcell fate coupled by T-bet and eomesodermin. Nat. Immunol. 2005, 6:1236-1244.
26. Kadow S., Jux B., Zahner S.P., Wingerath B., Chmill S., Clausen B.E., Hengstler J., Esser C. Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta Tcells in the murine epidermis. J.Immunol. 2011, 187:3104-3110.
27. Kashii Y., Giorda R., Herberman R.B., Whiteside T.L., Vujanovic N.L. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J.Immunol. 1999, 163:5358-5366.
28. Kiss E.A., Vonarbourg C., Kopfmann S., Hobeika E., Finke D., Esser C., Diefenbach A. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
29. Klose C.S., Kiss E.A., Schwierzeck V., Ebert K., Hoyler T., d'Hargues Y., Göppert N., Croxford A.L., Waisman A., Tanriver Y., Diefenbach A. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells. Nature 2013, 494:261-265.
30. Kremer J., Gleichmann E., Esser C. Thymic stroma exposed toarylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation. J.Immunol. 1994, 153:2778-2786.
31. Lee J.S., Cella M., McDonald K.G., Garlanda C., Kennedy G.D., Nukaya M., Mantovani A., Kopan R., Bradfield C.A., Newberry R.D., Colonna M. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2012, 13:144-151.
32. Magnusson M., Sierra M.I., Sasidharan R., Prashad S.L., Romero M., Saarikoski P., Van Handel B., Huang A., Li X., Mikkola H.K. Expansion on stromal cells preserves the undifferentiated state of human hematopoietic stem cells despite compromised reconstitution ability. PLoS One 2013, 8:e53912.
33. Marcucci G., Radmacher M.D., Maharry K., Mrózek K., Ruppert A.S., Paschka P., Vukosavljevic T., Whitman S.P., Baldus C.D., Langer C., et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N.Engl. J. Med. 2008, 358:1919-1928.
34. Mrózek E., Anderson P., Caligiuri M.A. Role of interleukin-15 inthe development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996, 87:2632-2640.
35. Murray I.A., Morales J.L., Flaveny C.A., Dinatale B.C., Chiaro C., Gowdahalli K., Amin S., Perdew G.H. Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity. Mol. Pharmacol. 2010, 77:247-254.
36. Opitz C.A., Litzenburger U.M., Sahm F., Ott M., Tritschler I., Trump S., Schumacher T., Jestaedt L., Schrenk D., Weller M., et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011, 478:197-203.
37. Platzer B., Richter S., Kneidinger D., Waltenberger D., Woisetschläger M., Strobl H. Aryl hydrocarbon receptor activation inhibits invitro differentiation of human monocytes and Langerhans dendritic cells. J.Immunol. 2009, 183:66-74.
38. Powell N., Walker A.W., Stolarczyk E., Canavan J.B., Gökmen M.R., Marks E., Jackson I., Hashim A., Curtis M.A., Jenner R.G., et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 2012, 37:674-684.
39. Qiu J., Heller J.J., Guo X., Chen Z.M., Fish K., Fu Y.X., Zhou L. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012, 36:92-104.
40. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
41. Rannug U., Rannug A., Sjöberg U., Li H., Westerholm R., Bergman J. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem. Biol. 1995, 2:841-845.
42. Satoh-Takayama N., Lesjean-Pottier S., Vieira P., Sawa S., Eberl G., Vosshenrich C.A., Di Santo J.P. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J.Exp. Med. 2010, 207:273-280.
43. Shibuya A., Nagayoshi K., Nakamura K., Nakauchi H. Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1995, 85:3538-3546.
44. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., Fujii-Kuriyama Y., Ishikawa T. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 2000, 97:779-782.
45. Shin J.H., Zhang L., Murillo-Sauca O., Kim J., Kohrt H.E., Bui J.D., Sunwoo J.B. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 2013, 110:12391-12396.
46. Smith K.J., Murray I.A., Tanos R., Tellew J., Boitano A.E., Bisson W.H., Kolluri S.K., Cooke M.P., Perdew G.H. Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism. J.Pharmacol. Exp. Ther. 2011, 338:318-327.
47. Sonnenberg G.F., Monticelli L.A., Alenghat T., Fung T.C., Hutnick N.A., Kunisawa J., Shibata N., Grunberg S., Sinha R., Zahm A.M., et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012, 336:1321-1325.
48. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2011, 12:21-27.
49. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N., Mebius R.E., et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat. Rev. Immunol. 2013, 13:145-149.
50. Stejskalova L., Dvorak Z., Pavek P. Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr. Drug Metab. 2011, 12:198-212.
51. Sun Y.V., Boverhof D.R., Burgoon L.D., Fielden M.R., Zacharewski T.R. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res. 2004, 32:4512-4523.
52. Swanson H.I., Bradfield C.A. The AH-receptor: genetics, structure and function. Pharmacogenetics 1993, 3:213-230.
53. Trotta R., Puorro K.A., Paroli M., Azzoni L., Abebe B., Eisenlohr L.C., Perussia B. Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. J.Immunol. 1998, 161:6648-6656.
54. Trotta R., Parihar R., Yu J., Becknell B., Allard J., Wen J., Ding W., Mao H., Tridandapani S., Carson W.E., Caligiuri M.A. Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood 2005, 105:3011-3018.
55. Trotta R., Chen L., Ciarlariello D., Josyula S., Mao C., Costinean S., Yu L., Butchar J.P., Tridandapani S., Croce C.M., Caligiuri M.A. miR-155 regulates IFN-γ production in natural killer cells. Blood 2012, 119:3478-3485.
56. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., Stockinger B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
57. Veldhoen M., Hirota K., Christensen J., O'Garra A., Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 Tcells. J.Exp. Med. 2009, 206:43-49.
58. Vonarbourg C., Mortha A., Bui V.L., Hernandez P.P., Kiss E.A., Hoyler T., Flach M., Bengsch B., Thimme R., Hölscher C., et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity 2010, 33:736-751.
59. Walker J.A., Barlow J.L., McKenzie A.N. Innate lymphoid cells-how did we miss them?. Nat. Rev. Immunol. 2013, 13:75-87.
60. Wei Y.D., Helleberg H., Rannug U., Rannug A. Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole. Chem. Biol. Interact. 1998, 110:39-55.
61. Yu J., Wei M., Becknell B., Trotta R., Liu S., Boyd Z., Jaung M.S., Blaser B.W., Sun J., Benson D.M., et al. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 2006, 24:575-590.
62. Yu J., Freud A.G., Caligiuri M.A. Location and cellular stages of natural killer cell development. Trends Immunol. 2013, 34:573-582.
63. Zhao B., Degroot D.E., Hayashi A., He G., Denison M.S. CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor. Toxicol. Sci. 2010, 117:393-403.